DavidPerlmutterMD · 2022-03-28 · David Perlmutter (host), Max Lugavere
What to Eat for Optimal Brain Health - with Max Lugavere | The Empowering Neurologist EP. 147
48 research-tied claims examined: 2 contradicted 5 overstated 5 context 33 supported 3 unverified
5 Overstated
An individual who reaches the age of 85 has a 50% chance of developing Alzheimer's disease.
"if you live to be age 85, it's going to be 50/50 anyway." (said at 0:13:40)
The claim that reaching age 85 carries a 50% chance (or 50/50 odds) of developing Alzheimer's disease substantially overstates epidemiological estimates. According to large-scale epidemiological data and annual reports from the Alzheimer's Association, approximately one-third (about 32% to 34%) of individuals aged 85 and older have Alzheimer's dementia, not half. Furthermore, the remaining lifetime risk of developing Alzheimer's disease at or after age 85 is estimated to be well below 50% (roughly 10% to 15% for men and 15% to 20% for women, depending on mortality and risk factors). While age remains the strongest known risk factor for Alzheimer's dementia, reaching 85 does not confer a 50/50 probability.
Fructose consumption inhibits leptin signaling and stimulates appetite.
"the most powerful food that we would consume that would tell us to keep eating, that inhibits leptin, that makes us want to eat more, is fructose." (said at 0:28:35)
While dietary fructose ingestion results in lower acute postprandial insulin and leptin secretion compared with glucose, and chronic high-fructose diets have been linked to leptin resistance and increased energy intake in animal and human studies, characterizing fructose as the 'most powerful' food that inhibits leptin and stimulates appetite is an overstatement. Multiple dietary factors, particularly overall positive energy balance, high saturated fat, and mixed high-sugar diets, contribute substantially to impaired leptin signaling and reduced satiety.
- context: High-fructose corn syrup, energy intake, and appetite regulation. (The American journal of clinical nutrition 2008) · cited 81x in the literature
"Compared with pure glucose, fructose is thought to be associated with insufficient secretion of insulin and leptin and suppression of ghrelin. However, when HFCS is compared with sucrose, the more commonly consumed sweetener, such differences are not apparent, and appetite and energy intake do not differ in the short-term." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Effects of Consuming Sugar-Sweetened Beverages for 2 Weeks on 24-h Circulating Leptin Prof… (Nutrients 2020) · cited 39x in the literature
"Fructose-SB decreased (-14 ng/mL × 24 h, p = 0.0006) and sucrose-SB increased (+25 ng/mL × 24 h, p = 0.025 vs. Week 0; p = 0.0008 vs. fructose-SB) 24-h leptin AUC. The Δad libitum food intake and Δbody weight were not influenced by circulating leptin in young adults consuming sugar-SB for 2 weeks." (abstract, results, passage verified)
pubmedfull study (doi) - context: The Leptin System and Diet: A Mini Review of the Current Evidence. (Frontiers in endocrinology 2021) · cited 122x in the literature
"Albeit some limitations (e.g., limited rigor, small samples sizes), studies in animals and humans show that diets high in fat, carbohydrates, fructose, and sucrose, and low in protein are drivers of leptin resistance." (abstract, results, passage verified)
pubmedfull study (doi)
Elevated serum sodium following a high-salt meal triggers the body to produce endogenous fructose, signaling fat synthesis via uric acid.
"We know that when the sodium goes up, as in after a very highly salted meal, it triggers the body to produce its own fructose, and that is a signal to make fat through uric acid." (said at 0:36:27)
The proposed pathway—where high sodium/osmolarity upregulates aldose reductase to drive endogenous fructose synthesis via the polyol pathway, which in turn leads to fructokinase-mediated uric acid generation and downstream lipogenesis—is supported by preclinical rodent and in vitro studies. However, presenting this as an established physiological consequence of a single high-salt meal in humans overstates the evidence, which currently relies almost entirely on animal models, cell cultures, and observational associations.
- supports: High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fr… (Proceedings of the National Academy of Sciences of the United States of America 2018) · cited 283x in the literature
"Here we show that high intake of salt activates the aldose reductase-fructokinase pathway in the liver and hypothalamus, leading to endogenous fructose production with the development of leptin resistance and hyperphagia that cause obesity, insulin resistance, and fatty liver." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fa… (The Journal of biological chemistry 2019) · cited 126x in the literature
"Moreover, fructose metabolism yields uric acid, which is highly associated with NAFLD. Here, using biochemical assays, reporter gene expression, and confocal fluorescence microscopy, we investigated whether uric acid regulates aldose reductase, a key enzyme in the polyol pathway." (abstract, results, passage verified)
pubmedfull study (doi)
A meta-analysis published in a JAMA journal by Dr. Richard Kennedy found that Alzheimer's patients taking cholinesterase inhibitor drugs experienced more rapid cognitive decline compared to matched non-users.
"A Dr. Richard Kennedy publishing in the journal JAMA, Journal of the American Medical Association network journal, published a meta-analysis, I think 12 studies, several thousand people, and he demonstrated quite convincingly that those individuals who do take that drug actually have more rapid cognitive decline in comparison to matched individuals who do not take the so-called magic Alzheimer's pill." (said at 0:42:22)
Dr. Richard E. Kennedy and colleagues published a meta-analysis in JAMA Network Open (2018) analyzing 10 Alzheimer disease clinical trial cohorts (2,714 participants) examining concomitant medication use. They found that participants taking cholinesterase inhibitors (ChEIs) or memantine exhibited a greater annual rate of cognitive decline on the ADAS-cog (1.4 points/year; 95% CI, 0.1-2.7) compared to those taking neither. However, the speaker overstates the causal and methodological nature of the findings: this was an observational analysis within clinical trials, not a matched causal trial demonstrating that the medication itself accelerates decline. The authors explicitly cautioned that this association is likely subject to confounding (such as confounding by indication, where patients with faster-progressing or more severe disease are more likely to be prescribed medication).
Having type 2 diabetes may quadruple a person's risk for developing Alzheimer's disease.
"If you're type 2 diabetic, you may have quadrupled your risk for Alzheimer's." (said at 0:51:18)
Large meta-analyses confirm that diabetes is associated with an increased risk of developing Alzheimer's disease, but the relative risk is substantially lower than a fourfold (quadrupled) increase. A systematic review and meta-analysis involving over 3.3 million participants found that diabetes was associated with approximately a 36% increase in Alzheimer's risk (hazard ratio 1.36, 95% CI: 1.19–1.55), with subgroup estimates ranging between 1.29 and 1.45. While type 2 diabetes is a recognized independent risk factor for cognitive decline, asserting that it quadruples Alzheimer's risk significantly overstates the evidence.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.